PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
0.8640
-0.0187 (-2.12%)
At close: May 12, 2025, 4:00 PM
0.8899
+0.0259 (3.00%)
After-hours: May 12, 2025, 4:27 PM EDT
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $44.87 million as of May 12, 2025. Its market cap has decreased by -48.39% in one year.
Market Cap
44.87M
Enterprise Value
-119.85M
1-Year Change
-48.39%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $44.87M, a decrease of -97.22%. That is a compound annual growth rate of -53.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 45.84M | -41.33% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | 2.75B | 70.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |